Compare HROW & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | WINA |
|---|---|---|
| Founded | 1998 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 1993 |
| Metric | HROW | WINA |
|---|---|---|
| Price | $50.54 | $436.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $68.86 | N/A |
| AVG Volume (30 Days) | ★ 616.6K | 84.0K |
| Earning Date | 11-10-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | N/A | ★ 2.56 |
| EPS | N/A | ★ 11.21 |
| Revenue | ★ $250,042,000.00 | $84,517,400.00 |
| Revenue This Year | $38.96 | $7.05 |
| Revenue Next Year | $43.38 | $3.60 |
| P/E Ratio | ★ N/A | $38.77 |
| Revenue Growth | ★ 47.83 | 3.35 |
| 52 Week Low | $20.85 | $295.79 |
| 52 Week High | $54.85 | $527.37 |
| Indicator | HROW | WINA |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 58.38 |
| Support Level | $46.58 | $412.40 |
| Resistance Level | $54.85 | $439.70 |
| Average True Range (ATR) | 2.51 | 17.03 |
| MACD | 0.01 | 2.50 |
| Stochastic Oscillator | 58.95 | 84.53 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.